Morpho Komodo LLC v. BLU Products INc., No. 2:15-cv-01100 (E.D. Tex. July 25, 2016)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

On May 18, 2016, the Court held a hearing to determine the proper construction of the disputed claim terms in United States Patent Nos. 7,350,078 (“the ’078 Patent”), 7,725,725 (“the ’725 Patent”), and 8,429,415 (“the ’415 Patent”) (collectively, the “Asserted Patents”). After considering the intrinsic and extrinsic evidence presented by the parties at the hearing and in the briefing (Dkt. Nos. 136, 142, and 143), the Court issues this Claim Construction Memorandum and Order. See Phillips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005); Teva Pharm.